89
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Evaluation of the efficacy and safety of nivolumab in the second- or later-line treatment of patients with locally advanced/metastatic non-small cell lung cancer in Türkiye: a retrospective multicenter non-interventional registry study

, , , , , , ORCID Icon, , , , , , , , , , , , , , ORCID Icon, & show all
Received 21 Nov 2023, Accepted 20 May 2024, Published online: 22 Jun 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.